Bond AbbVie 2.95% ( US00287YBV02 ) in USD
Issuer | AbbVie |
Market price | 100 % ▲ |
Country | United States |
ISIN code | US00287YBV02 ( in USD ) |
Interest rate | 2.95% per year ( payment 2 times a year) |
Maturity | 20/11/2026 |
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
Minimal amount | 2 000 USD |
Total amount | 3 990 755 000 USD |
Cusip | 00287YBV0 |
Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) |
Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) |
Next Coupon | 21/05/2025 ( In 105 days ) |
Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YBV02, pays a coupon of 2.95% per year. The coupons are paid 2 times per year and the Bond maturity is 20/11/2026 The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YBV02, was rated Baa2 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YBV02, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |